SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp. engages in the design, manufacture, and launch of rockets and spacecrafts. It provides satellite communication services. The company was founded by Elon Reeve Musk on March 14, 2002 and is headquartered in Hawthorne, CA.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is dominating market conversation following its historic IPO, with traders divided between FOMO-driven buying and warnings that the stock is severely overvalued compared to its current earnings. While many investors are positioning for long-term growth as part of the broader space economy, others are treating the debut as a highly volatile scalp play and speculating on an inevitable pullback as institutional liquidity rotates into the name.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently trending as investors weigh the impact of the high-profile SpaceX debut alongside its own recent inclusion in the Nasdaq-100 index. Community discourse is sharply divided between those who believe the broader space sector is undergoing a massive structural revaluation and those who fear that speculative capital is rotating out of secondary proxies and into SpaceX, creating short-term volatility.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech 100 is seeing high volatility as investors weigh its exposure to SpaceX, Anthropic, and OpenAI against the implications of an ongoing ATM offering and broader market rotation. Community sentiment is deeply divided, with many debating whether the stock is a strategic opportunity to acquire private assets at a discount to potential NAV, or if the stock is facing selling pressure as market participants shift capital toward direct exposure to the upcoming SpaceX IPO.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is currently trending as the community debates a potential turning point following the resolution of a fee dispute with Publicis. While some investors view the settlement as a catalyst for a short squeeze and long-term recovery, others remain skeptical, citing persistent negative sentiment, executive turnover, and the stock's inability to maintain momentum.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing significant volatility as market liquidity rotates into the high-profile SpaceX IPO, causing a sector-wide pullback despite upcoming satellite launch catalysts. While some investors are concerned about potential sector drag and aggressive institutional selling, others view the sharp decline as a strategic buying opportunity for a long-term play on direct-to-device broadband technology.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as investors react to positive Phase 1 clinical data for subcutaneous Briumvi in myasthenia gravis and a concurrent initiation of a Phase 2 trial. The stock is seeing high social media volume fueled by speculation about a potential buyout and community optimism regarding Briumvi's expanding market potential.

Tema ETF Trust - Tema Space Innovators ETF

Tema Space Innovators ETF

Investors are aggressively piling into the Tema Space Innovators ETF (NASA) as a proxy play for the highly anticipated SpaceX IPO, though the fund is seeing significant price volatility as capital rotates into the main event. Community members remain polarized, with many viewing the recent dips as a strategic buying opportunity in a sector they believe has long-term growth potential, while others fear the ETF could face short-term selling pressure from IPO-driven liquidity shifts.

EchoStar Corp. engages in the design, development, and distribution of digital set-top boxes and products for direct-to-home satellite service providers. It operates through the following business segments: Pay-TV, Retail Wireless, and Broadband and Satellite Services. The Pay-TV segment business strategy is to be the best provider of video services in the United States by providing products with the best technology, outstanding customer service, and great value. The Retail Wireless segment offers Retail Wireless services as well as a competitive portfolio of wireless devices. The Broadband and Satellite Services segment business strategy is to maintain and improve leadership position and competitive advantage through development of technologies and services marketed to selected sectors within the consumer, enterprise and government markets globally. The company was founded by Charlie William Ergen, Candy Ergen, and James DeFranco in 1980 and is headquartered in Englewood, CO.

EchoStar Corp - Ordinary Shares - Class A

EchoStar Corp

EchoStar is currently in focus as investors analyze the stock's significant indirect exposure to the upcoming SpaceX IPO, viewing it as a potential value proxy for the space sector. Community sentiment is deeply divided between long-term holders betting on the revaluation of EchoStar's satellite assets and SpaceX stake, and short-sellers who are expressing concerns over the company's debt load and capital structure.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as the company officially kicks off public R2 deliveries and opens orders for reservation holders, sparking intense debate among investors over pricing strategies and long-term profitability. While the community is split between bullish sentiment over positive R2 reviews and concerns regarding the stock's recent volatility and management's communication style, active discussions are centered on whether this launch represents a "Model 3 moment" for the company.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is trending as shareholders weigh a beat-and-raise earnings report against concerns regarding a leadership vacuum, as both the CEO and CFO are departing. The community is sharply divided, with many citing the company's aggressive buyback authorization and strong fundamentals as a generational value opportunity, while others express deep skepticism over whether Adobe's subscription model can withstand competition from emerging generative AI tools.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's Why Incyte (INCY) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Intellia Therapeutics (NTLA) Down 7.9% Since Last Earnings Report: Can It Rebound?

Intellia Therapeutics (NTLA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Incyte to Buy Vega Therapeutics in Hematology Deal Worth Up to $2B

Incyte will acquire Vega Therapeutics for up to $2B, adding late-stage VWD candidate VGA039 and expanding its hematology growth prospects.

Incyte Bets $1.25 Billion On Rare Bleeding Disorder Drug With Blockbuster Potential

Incyte to acquire Vega Therapeutics for $1.25 billion upfront, adding a rare bleeding disorder candidate with blockbuster potential in 2030s.read more...

Here's Why Incyte (INCY) is a Strong Growth Stock

Incyte to Acquire Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio into Bleeding Disorders

Incyte (Nasdaq:INCY) announced today it has entered into a definitive agreement to acquire Vega Therapeutics, Inc., a wholly owned subsidiary of Star Therapeutics, LLC, for $1.25 billion. Star Therapeutics will be eligible to receive up to $750 million in additional payments upon the achievement of...

Adma Biologics (ADMA) Down 5.8% Since Last Earnings Report: Can It Rebound?

Adma Biologics (ADMA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Mirum Pharmaceuticals and Incyte Announce Pivotal Late-Breaking Results for Zilurgisertib in Fibrodysplasia Ossificans Progressiva Accepted for Presentation at ENDO 2026

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) and Incyte (Nasdaq: INCY) today announced that pivotal Phase 2 results from the PROGRESS study evaluating zilurgisertib, an investigational ALK2 inhibitor, in patients with fibrodysplasia ossificans progressiva (FOP) will be presented at ENDO 2026, the...

Wednesday's ETF Movers: FBT, URA

In trading on Wednesday, the First Trust NYSE Arca Biotechnology Index Fund ETF is outperforming other ETFs, up about 2.2% on the day. Components of that ETF showing particular strength include shares of Neurocrine Biosciences, up about 6.2% and shares of Incyte, up about 6.2...

Incytes Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi/Minjuvi) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi/Minjuvi), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide...

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.

INCYIncyte Corp.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest INCY News